Dermatomyositis skin transcriptomic signature
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA527138 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Dermatomyositis is a cutaneous and muscular auto-immune condition associated with specific autoantibodies. MDA5 antibody-associated DM has higher mortality. We demonstrate here for the first time using skin microarray analysis that MDA5+ DM is associated with a greater type I interferon skin signature than MDA5- DM, mainly involving the IFN- κ member produced by skin keratinocytes
2019-10-27 | GSE128314 | GEO
Project description:The purpose of this study was to use global gene expression analysis to determine major functional pathways and genes dysregulated in the skin of active rashes of dermatomyositis patients. These data will be used to help assign a diagnosis to skin biopsies from patients with rashes that are not clearly dermatomyositis. In addition, we will correlate gene expression changes with specific histopathologic changes in skin biopsies that are taken adjacent to those analyzed for gene expression analysis. Finally, these data will be used to search for genes and pathways that are associated with clinical outcomes and autoantibody status in this cohort of patients.
2013-04-20 | GSE46239 | GEO
Project description:Background: Dermatomyositis (DM) is an autoimmune disease that mainly affects the skin, muscle, and lung. The pathogenesis of skin inflammation in DM is not well understood. Methodology and Findings: We analyzed genome-wide expression data in DM skin and compared them to those from healthy controls. We observed a robust upregulation of interferon (IFN)-inducible genes in DM skin, as well as several other gene modules pertaining to inflammation, complement activation, and epidermal activation and differentiation. The interferon (IFN)-inducible genes within the DM signature were present not only in DM and lupus, but also cutaneous herpes simplex-2 infection and to a lesser degree, psoriasis. This IFN signature was absent or weakly present in atopic dermatitis, allergic contact dermatitis, acne vulgaris, systemic sclerosis, and localized scleroderma/morphea. We observed that the IFN signature in DM skin appears to be more closely related to type I than type II IFN based on in vitro IFN stimulation expression signatures. However, quantitation of IFN mRNAs in DM skin shows that the majority of known type I IFNs, as well as IFN gamma, are overexpressed in DM skin. In addition, both IFN-beta and IFN-gamma (but not other type I IFN) transcript levels were highly correlated with the degree of the in vivo IFN transcriptional response in DM skin. disease_state_design
2012-01-12 | E-GEOD-32245 | biostudies-arrayexpress
Project description:The microarray experiment was employed to evaluate the gene expressions in skin lesions of dermatomyositis and healthy controls.
2020-04-06 | GSE142807 | GEO
Project description:Background: Dermatomyositis (DM) is an autoimmune disease that mainly affects the skin, muscle, and lung. The pathogenesis of skin inflammation in DM is not well understood. Methodology and Findings: We analyzed genome-wide expression data in DM skin and compared them to those from healthy controls. We observed a robust upregulation of interferon (IFN)-inducible genes in DM skin, as well as several other gene modules pertaining to inflammation, complement activation, and epidermal activation and differentiation. The interferon (IFN)-inducible genes within the DM signature were present not only in DM and lupus, but also cutaneous herpes simplex-2 infection and to a lesser degree, psoriasis. This IFN signature was absent or weakly present in atopic dermatitis, allergic contact dermatitis, acne vulgaris, systemic sclerosis, and localized scleroderma/morphea. We observed that the IFN signature in DM skin appears to be more closely related to type I than type II IFN based on in vitro IFN stimulation expression signatures. However, quantitation of IFN mRNAs in DM skin shows that the majority of known type I IFNs, as well as IFN gamma, are overexpressed in DM skin. In addition, both IFN-beta and IFN-gamma (but not other type I IFN) transcript levels were highly correlated with the degree of the in vivo IFN transcriptional response in DM skin.
2012-01-12 | GSE32245 | GEO
Project description:The purpose of this study was to use global gene expression analysis to determine major functional pathways and genes dysregulated in the skin of active rashes of dermatomyositis patients. These data will be used to help assign a diagnosis to skin biopsies from patients with rashes that are not clearly dermatomyositis. In addition, we will correlate gene expression changes with specific histopathologic changes in skin biopsies that are taken adjacent to those analyzed for gene expression analysis. Finally, these data will be used to search for genes and pathways that are associated with clinical outcomes and autoantibody status in this cohort of patients. Gene expression profiling of healthy donor and dermatomyositis patient skin biopsy specimens.
2013-04-20 | E-GEOD-46239 | biostudies-arrayexpress
Project description:Adult-onset dermatomyositis (DM) is a systemic autoimmune disease associated with an elevated risk of malignancy, yet the cellular and molecular features distinguishing cancer-associated DM from non-cancer DM remain poorly defined. Here, we conduct a comprehensive single-cell RNA sequencing analysis of adult-onset DM skin, including lesional and non-lesional samples, alongside cutaneous lupus erythematosus (CLE) and healthy control skin, to characterize immune and stromal cell states and disease-specific transcriptional programs. We identify distinct immune-stromal cell populations that differentiate cancer-associated DM from non-cancer-associated DM and CLE, including a vascular injury phenotype with hypoxia and metabolic reprogramming enriched in cancer-associated DM. These findings nominate cell-state-defining molecular features as potential biomarkers for cancer screening and therapeutic targeting in adult dermatomyositis.
2026-06-08 | GSE334588 | GEO
Project description:Transcriptomic profiling of dermatomyositis lesions.
| PRJNA598373 | ENA
Project description:Dermatomyositis is an autoimmune disease that primarily affects the skin and muscles. Perifascicular atrophy is a characteristic feature of dermatomyositis, yet its underlying mechanisms remain unclear. Hereby we conducted spatial transcriptomics to study the changes in the RNA expression in the muscle fibers with perifascicular atrophy from patients with juvenile and adult dermatomyositis, compared with muscles with non-atrophic areas. Our findings provide new insights into the molecular mechanisms underlying perifascicular atrophy and highlight potential pathways for future investigation.
2025-10-01 | GSE285226 | GEO
Project description:Single-cell transcriptomic atlas of adult dermatomyositis, cutaneous lupus erythematosus and healthy skin
| PRJNA1475987 | ENA